Correlation Between Pharmagreen Biotech and BC Bud

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharmagreen Biotech and BC Bud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmagreen Biotech and BC Bud into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharmagreen Biotech and The BC Bud, you can compare the effects of market volatilities on Pharmagreen Biotech and BC Bud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmagreen Biotech with a short position of BC Bud. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmagreen Biotech and BC Bud.

Diversification Opportunities for Pharmagreen Biotech and BC Bud

-0.27
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharmagreen and BCBCF is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pharmagreen Biotech and The BC Bud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BC Bud and Pharmagreen Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmagreen Biotech are associated (or correlated) with BC Bud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BC Bud has no effect on the direction of Pharmagreen Biotech i.e., Pharmagreen Biotech and BC Bud go up and down completely randomly.

Pair Corralation between Pharmagreen Biotech and BC Bud

Given the investment horizon of 90 days Pharmagreen Biotech is expected to generate 5.32 times less return on investment than BC Bud. But when comparing it to its historical volatility, Pharmagreen Biotech is 4.25 times less risky than BC Bud. It trades about 0.12 of its potential returns per unit of risk. The BC Bud is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  0.88  in The BC Bud on September 4, 2024 and sell it today you would earn a total of  3.67  from holding The BC Bud or generate 417.05% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.44%
ValuesDaily Returns

Pharmagreen Biotech  vs.  The BC Bud

 Performance 
       Timeline  
Pharmagreen Biotech 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmagreen Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly fragile fundamental drivers, Pharmagreen Biotech demonstrated solid returns over the last few months and may actually be approaching a breakup point.
BC Bud 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in The BC Bud are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental indicators, BC Bud reported solid returns over the last few months and may actually be approaching a breakup point.

Pharmagreen Biotech and BC Bud Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharmagreen Biotech and BC Bud

The main advantage of trading using opposite Pharmagreen Biotech and BC Bud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmagreen Biotech position performs unexpectedly, BC Bud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BC Bud will offset losses from the drop in BC Bud's long position.
The idea behind Pharmagreen Biotech and The BC Bud pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings